A method for inhibiting microbial clogging of drip irrigation emitters, belonging to the technical field of water-saving irrigation. The method includes the following steps: (1) Use developmental molecular ecological network analysis to determine the key bacteria causing the clogging of drip irrigation emitters, and then carry out screening of antagonistic bacteria to inhibit the clogging of drip irrigation emitters; (2) Ferment the selected antagonistic bacteria in a medium containing biogas slurry, to generate bacterial antagonist; (3) Apply the bacterial antagonist to drip irrigation system. The method uses the molecular ecological network analysis method to obtain key bacteria that cause the growth of biofilm in drip irrigation emitters, and then combines the principle of microbial antagonism to screen out the antagonistic bacteria that can antagonize the growth of biofilm, so as to inhibit the growth of biofilm in irrigation emitters.

A method for inhibiting microbial clogging of drip irrigation emitters, belonging to the technical field of water-saving irrigation. The method includes the following steps: (1) Use developmental molecular ecological network analysis to determine the key bacteria causing the clogging of drip irrigation emitters, and then carry out screening of antagonistic bacteria to inhibit the clogging of drip irrigation emitters; (2) Ferment the selected antagonistic bacteria in a medium containing biogas slurry, to generate bacterial antagonist; (3) Apply the bacterial antagonist to drip irrigation system. The method uses the molecular ecological network analysis method to obtain key bacteria that cause the growth of biofilm in drip irrigation emitters, and then combines the principle of microbial antagonism to screen out the antagonistic bacteria that can antagonize the growth of biofilm, so as to inhibit the growth of biofilm in irrigation emitters.

The invention relates to methods for spectrometric characterization of a test cell substrate. The characterization comprises taxonomic classification and determination of a property of interest of the test cell substrate. The characterization may be based on mass-spectrometric measurement data. The property of interest may be a resistance or susceptibility to a growth-influencing factor. After comparing first spectrometric measurement data of the test cell substrate with a provided reference library, a sub-library is created comprising those reference datasets from the reference library that are classified as allowing a taxonomic classification of the test cell substrate. Second spectrometric measurement data after a second preparation of the test cell substrate under conditions that serve to determine a property of interest of the test cell substrate is compared with the sub-library and allow a reliable determination of the property of interest.

A marker for determining a mental disease is provided. The marker can be used in an objective diagnosis of such a mental disease. The marker contains one or more enterobacteria of Bifidobacterium, Lactobacillus, Lactobacillus brevis, Lactobacillus reuteri subgroup, Lactobacillus sakei subgroup, Atopobium cluster, Bacteroides fragilis group, Enterococcus, Clostridium coccoides group, Clostridium leptum subgroup, Staphylococcus, Clostridium perfringens, and Enterobacteriaceae.

A marker for determining a mental disease is provided. The marker can be used in an objective diagnosis of such a mental disease. The marker contains one or more enterobacteria of Bifidobacterium, Lactobacillus, Lactobacillus brevis, Lactobacillus reuteri subgroup, Lactobacillus sakei subgroup, Atopobium cluster, Bacteroides fragilis group, Enterococcus, Clostridium coccoides group, Clostridium leptum subgroup, Staphylococcus, Clostridium perfringens, and Enterobacteriaceae.

A method and system for analyzing and/or estimating intestinal microflora of a subject. A digital image of a sample of feces of the subject is received by one or more processors. The digital image and/or one or more features extracted from the digital image is provided as input to a trained machine learning model which is configured to output a classification based on said input digital image and/or one or more features extracted from the digital image. Data indicative of one or more properties of the intestinal microflora of the subject based on the output image classification is determined by the one or more processors.

Dioxetane compounds represented by Formula I below, and methods of using the dioxetane compounds in the detection of presence or absence, quantification, and identification of microorganisms including bacteria, bacterial fragments (e.g., LPS, endotoxin), viruses, and fungi by means of chemiluminescence. ##STR00001##

Dioxetane compounds represented by Formula I below, and methods of using the dioxetane compounds in the detection of presence or absence, quantification, and identification of microorganisms including bacteria, bacterial fragments (e.g., LPS, endotoxin), viruses, and fungi by means of chemiluminescence. ##STR00001##

The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.

The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.